1.61
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
Using data models to predict 60 Degrees Pharmaceuticals Inc. stock movement2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Measuring 60 Degrees Pharmaceuticals Inc.’s beta against major indicesEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Live market analysis of 60 Degrees Pharmaceuticals Inc.Bond Market & Fast Gain Swing Trade Alerts - newser.com
What machine learning models say about 60 Degrees Pharmaceuticals Inc.Market Growth Review & Capital Protection Trading Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Predicting 60 Degrees Pharmaceuticals Inc. Equity Warrant trend using moving averagesWeekly Trend Recap & Verified Short-Term Plans - newser.com
Live market analysis of 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Investor Takeaways & Expert Approved Momentum Ideas - newser.com
60 Degrees Pharmaceuticals Inc. stock chart pattern explainedPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
What high frequency data says about 60 Degrees Pharmaceuticals Inc.Quarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Detecting support and resistance levels for 60 Degrees Pharmaceuticals Inc. Equity WarrantQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant outperform the marketJuly 2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Top chart patterns to watch in 60 Degrees Pharmaceuticals Inc.Quarterly Growth Report & Daily Momentum Trading Reports - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investorsTake Profit & Weekly Watchlist of Top Performers - newser.com
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - The Daily Jeffersonian
Is it time to cut losses on 60 Degrees Pharmaceuticals Inc.2025 Dividend Review & Community Driven Trade Alerts - newser.com
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Canton Repository
60 Degrees Pharmaceuticals stockholders approve board, equity plan amendment and reverse split - Investing.com
60 Degrees Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Visual trend scoring systems applied to 60 Degrees Pharmaceuticals Inc.2025 Dividend Review & Short-Term High Return Ideas - newser.com
Can 60 Degrees Pharmaceuticals Inc. stock sustain market leadershipStop Loss & Free AI Powered Buy and Sell Recommendations - newser.com
How buybacks impact 60 Degrees Pharmaceuticals Inc. stock valueJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Is Rajeswari Infrastructure Limiteds Business Model Sustainable Long TermResistance Breakout Alerts & Affordable Investment Tips - earlytimes.in
60 Degrees Pharma names first chronic babesiosis trial B-FREE By Investing.com - Investing.com Canada
60 Degrees Pharma names first chronic babesiosis trial B-FREE - Investing.com India
60 Degrees Pharmaceuticals Launches B-FREE Chronic Babesiosis Study Following Patient Naming Competition and $5K Charity Donation - Quiver Quantitative
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study - GlobeNewswire
12-Month Phase 2 Study: 60 Degrees Pharma's B-FREE Trial of ARAKODA® for Chronic Babesiosis - Stock Titan
Is 60 Degrees Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Why retail investors pile into 60 Degrees Pharmaceuticals Inc. stock2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Can machine learning forecast 60 Degrees Pharmaceuticals Inc. Equity Warrant recoveryJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc Equity Warrant a good long term investmentStraddle and Strangle Trades & High Yield Market Growth - earlytimes.in
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):